News
-
-
PRESS RELEASE
Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025
Revelation Biosciences, Inc. reports financial results for Q3 2025 and highlights milestone achievements in clinical study and fundraising, focusing on rebalancing inflammation for health optimization -
PRESS RELEASE
Innodata Announces New Leadership Appointments to Support Next Phase of Growth
Innodata Inc. announces executive management & Board appointments to support rapid growth in generative AI solutions. Rahul Singhal appointed President & CRO, Daniel Callahan & Richard Clarke to Board, Jack Abuhoff as Chairman, Stewart Massey as Lead Independent Director. Third Quarter 2025 results released -
-
-
PRESS RELEASE
Protagonist Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Protagonist Therapeutics reports financial results and updates on NDA submissions for icotrokinra and rusfertide, as well as progress in clinical trials for PN-881 and IND-enabling studies for PN-477sc and PN-477o -
-
REGULATED PRESS RELEASE
Merger by absorption of the French company Interparfums Holding SAS by the French company Interparfums SA
French company Interparfums SA plans merger by absorption with Interparfums Holding SAS. AMF decides no public offer needed, General Meeting on December 17, 2025, details available online -
PRESS RELEASE
ACQUISITION DE 97,68% DE LA SOCIÉTÉ DE TAYNINH SUIVIE D'UNE OFFRE PUBLIQUE D'ACHAT SIMPLIFIÉE (SANS INTENTION DE RETRAIT OBLIGATOIRE) AU PRIX DE 0,11EUR PAR ACTION
Unibail-Rodamco-Westfield cède sa participation dans Société de Tayninh à trois investisseurs. Projet d'offre publique d'achat à venir -